New insider activity at Firefly Neuroscience ( (AIFF) ) has taken place on October 22, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Windsor Private Capital LP, a significant shareholder in Firefly Neuroscience, has recently sold 130,753 shares of the company’s stock. This transaction is valued at $289,731, marking a notable shift in the shareholder’s investment portfolio.
Spark’s Take on AIFF Stock
According to Spark, TipRanks’ AI Analyst, AIFF is a Underperform.
Firefly Neuroscience’s stock is heavily impacted by its significant financial instability, marked by persistent losses, negative equity, and cash flow deficits. The bearish technical indicators further weigh down the score. Although the acquisition of Evoke Neuroscience presents a positive strategic move, it does not sufficiently mitigate the fundamental financial and valuation challenges. Overall, the stock faces a challenging outlook with limited upside potential.
To see Spark’s full report on AIFF stock, click here.
More about Firefly Neuroscience
YTD Price Performance: -8.20%
Average Trading Volume: 1,698,407
Technical Sentiment Signal: Strong Sell
Current Market Cap: $32.68M